Most relevant here, up‐regulation of the SGOC pathway correlated with MYCN amplification in neuroblastoma, and MYCN sensitized neuroblastoma cells to pharmacological inhibition of one of its components, phosphoglycerate dehydrogenase [250]. Here, PHGDH is linked to neuroblastoma.